Loss to follow-up in the Australian HIV Observational Database
Antiviral Therapy · 2015-10 · 20 (7) · 731-741
DOI: 10.3851/imp2916 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Antiviral Therapy, online erschienen am 01.10.2014. Verfasst von Hamish McManus und 12 weiteren Autor:innen. Beteiligte Einrichtung: The Kirby Institute, UNSW Australia, Sydney, Australia. hmcmanus@kirby.unsw.edu.au. Hauptthemen laut MEDLINE: Population Surveillance. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Background
Loss to follow-up (LTFU) in HIV-positive cohorts is an important surrogate for interrupted clinical care, which can potentially influence the assessment of HIV disease status and outcomes. After preliminary evaluation of LTFU rates and patient characteristics, we evaluated the risk of mortality by LTFU status in a high-resource setting.
Methods
Rates of LTFU were measured in the Australian HIV Observational Database for a range of patient characteristics. Multivariate repeated measures regression methods were used to identify determinants of LTFU. Mortality by LTFU status was ascertained using linkage to the National Death Index. Survival following combination antiretroviral therapy initiation was investigated using the Kaplan–Meier (KM) method and Cox proportional hazards models.
Results
Of 3,413 patients included in this analysis, 1,632 (47.8%) had at least one episode of LTFU after enrolment. Multivariate predictors of LTFU included viral load (VL)>10,000 copies/ml (rate ratio [RR] 1.63; 95% CI 1.45, 1.84; ref ≤400), time under follow-up (per year; RR 1.03; 95% CI 1.02, 1.04) and prior LTFU (per episode; RR 1.15; 95% CI 1.06, 1.24). KM curves for survival were similar by LTFU status ( P=0.484). LTFU was not associated with mortality in Cox proportional hazards models (univariate hazard ratio [HR] 0.93; 95% CI 0.69, 1.26) and multivariate HR 1.04 (95% CI 0.77, 1.43).
Conclusions
Increased risk of LTFU was identified amongst patients with potentially higher infectiousness. We did not find significant mortality risk associated with LTFU. This is consistent with timely re-engagement with treatment, possibly via high levels of unreported linkage to other health-care providers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The Kirby Institute, UNSW Australia, Sydney, Australia. hmcmanus@kirby.unsw.edu.au.
Förderung
- NIAID NIH HHS
Zitieren
APA
McManus, H., Petoumenos, K., Brown, K., Baker, D., Russell, D., Read, T., Smith, D., Wray, L., Giles, M., Hoy, J., Carr, A., Law, M. G., & Australian HIV Observational Database (2015). Loss to follow-up in the Australian HIV Observational Database. Antiviral Therapy, 20(7), 731-741. https://doi.org/10.3851/imp2916
Vancouver
McManus H, Petoumenos K, Brown K, Baker D, Russell D, Read T, et al. Loss to follow-up in the Australian HIV Observational Database. Antiviral Therapy. 2015;20(7):731-741. doi:10.3851/imp2916
BibTeX
@article{McManus2015,
author = {McManus, Hamish and Petoumenos, Kathy and Brown, Katherine and Baker, David and Russell, Darren and Read, Tim and Smith, Don and Wray, Lynne and Giles, Michelle and Hoy, Jennifer and Carr, Andrew and Law, Matthew G and Australian HIV Observational Database, Australian HIV Observational Database},
title = {Loss to follow-up in the Australian HIV Observational Database},
journal = {Antiviral Therapy},
year = {2015},
volume = {20},
number = {7},
pages = {731--741},
doi = {10.3851/imp2916}
}
EUVIMED